End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
777,000 KRW | -0.26% | -0.51% | +2.24% |
07:14am | US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz | MT |
05-06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.24% | 40.49B | |
-1.62% | 89.22B | |
-15.09% | 32.79B | |
+64.13% | 26.23B | |
-21.86% | 14.52B | |
-7.60% | 13.09B | |
-42.60% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B | |
-13.45% | 7.92B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics Co.,Ltd. Announces Sales Results for the Year 2020